EP 1507793 A2 20050223 - NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
Title (en)
NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
Title (de)
NEUTROKIN-ALPHA UND NEUTROKIN-ALPHA-SPLEISSVARIANTE
Title (fr)
NEUTROKINE-ALPHA ET VARIANT D'EPISSAGE DE NEUTROKINE-ALPHA
Publication
Application
Priority
- US 0232910 W 20021016
- US 32950801 P 20011017
- US 32974701 P 20011018
- US 33083501 P 20011031
- US 33147801 P 20011116
- US 33672601 P 20011207
- US 36854802 P 20020401
Abstract (en)
[origin: WO03033658A2] The present invention relates to nucleic acid molecules encoding Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides, including soluble forms of the extracellular domain. Neutrokine-alpha and/or Neutrokine-alphaSV polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. The invention further relates to antibodies or portions thereof that specifically bind Neutrokine-alpha and/or Neutrokine-alphaSV and diagnostic and therapeutic methods using these antibodies. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders using the compositions of the invention.
IPC 1-7
IPC 8 full level
A61K 38/19 (2006.01); A61K 51/08 (2006.01); C07K 14/52 (2006.01); C07K 14/525 (2006.01)
CPC (source: EP)
A61K 51/08 (2013.01); A61P 35/00 (2017.12); A61P 35/02 (2017.12); A61P 35/04 (2017.12); C07K 14/525 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03033658 A2 20030424; WO 03033658 A3 20040527; AU 2002351495 A1 20030428; CA 2476675 A1 20030424; EP 1507793 A2 20050223; EP 1507793 A4 20060201
DOCDB simple family (application)
US 0232910 W 20021016; AU 2002351495 A 20021016; CA 2476675 A 20021016; EP 02786413 A 20021016